NHTSA Chief may Re-open Fiat-Chrysler Gas Tank Investigation

National Highway Transportation Safety Administration (NHTSA) Administrator, Mark Rosekind, has indicated that the nation’s top automotive regulator may take a more aggressive stance toward Fiat-Chrysler following a massive $150 million judgment against the company over the burning death of 4 year-old Remi Walden due to an exploding gas tank on his Aunt’s 1999 Jeep Grand


Amazon Lawsuit a Warning Shot for Fake Review Peddlers

Amazon has been a pioneering company in a number of respects, from becoming the world’s largest online retailer to introducing cloud computing technology to the masses, and 20 years ago, when they implemented the user product review. On Wednesday, April 8th, the company took major strides in protecting the integrity of the review process when






Mass Torts Plaintiffs and the Federal Courts

With mass torts, plaintiffs and their attorneys have both state and federal options when considering where to pursue their claims.  The conventional wisdom has been that federal courts are “defense friendly”  – with substantive and procedural requirements and rules which may be unfamiliar or appear restrictive to attorneys who practice primarily in state courts. The


JPML Maintains Narrow Focus of Mirena MDL

The orders from the March JPML panel hearing have been posted, and the JPML issued an order denying a motion by a plaintiff to centralize her case in the Mirena IUD device litigation MDL proceeding in the SDNY.  In its order, the JPML indicated that centralization into the pending MDL was denied because the potential


Will Sprint Settlement finally Exorcize Ghosts of the Nextel Merger?

The fallout from one of the messiest mergers in American history appears to have entered its final stage on Monday, March 30th, when Sprint agreed to pay investors $131 million in a settlement dating back to the beleaguered 2005 Nextel acquisition. Lauded at the time as the creation of a telecom dynasty, technological incompatibility led


SCOTUS Denies Cert in Generic Preemption Case

Federal preemption of claims against generic drug manufacturers has prevented (or severely limited) the ability of users of generic drugs from bringing products liability claims premised upon the failure to warn.  Certain state courts have indicated that some state tort law claims may not necessarily be barred by federal preemption, but these “baby steps” potentially